Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥277.1bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥586.5bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥289.7bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income¥20.1bn2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥31.6bn2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥20.4bn2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥62.3bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥30.7bn2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥26.2bn2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥41.8bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥18.8bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥49.5bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥32.1bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥19.2bn2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥32.6bn2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥848.9bnat 2025-09-30Cons.Assets
Total assets¥813.8bnat 2025-03-31Cons.Assets
Total assets¥827.8bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥454.7bnat 2025-09-30Cons.Liabilities
Total liabilities¥438.8bnat 2025-03-31Cons.Liabilities
Net assets / equity¥394.2bnat 2025-09-30Cons.Net assets
Net assets / equity¥375.0bnat 2025-03-31Cons.Net assets
Net assets / equity¥392.3bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥64.7bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥65.1bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥64.4bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥64.8bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥64.4bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥68.4bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow¥32.8bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥93.4bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥50.7bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥26.5bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥47.9bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥29.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥7.8bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥48.9bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥24.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥70.92025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥181.442024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥116.182024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio44.7%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio44.2%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio45.5%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 65
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-04-01 → 2025-09-30¥9.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-04-01 → 2025-09-30¥2.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-04-01 → 2025-09-30¥7.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-04-01 → 2025-09-30¥400m
Reconciling Itemsreconcilingrevenue2025-04-01 → 2025-09-30−¥13.4bn
Reconciling Itemsreconcilingrevenue intersegment2025-04-01 → 2025-09-30−¥13.4bn
Engineering Plasticsreportable segmentrevenue2025-04-01 → 2025-09-30¥122.0bn
Engineering Plasticsreportable segmentrevenue external2025-04-01 → 2025-09-30¥121.9bn
Engineering Plasticsreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥106m
Engineering Plasticsreportable segmentsegment profit2025-04-01 → 2025-09-30¥11.5bn
Materialsreportable segmentrevenue2025-04-01 → 2025-09-30¥83.1bn
Materialsreportable segmentrevenue external2025-04-01 → 2025-09-30¥77.2bn
Materialsreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥5.9bn
Materialsreportable segmentsegment profit2025-04-01 → 2025-09-30¥5.0bn
Medical Healthcarereportable segmentrevenue2025-04-01 → 2025-09-30¥7.6bn
Medical Healthcarereportable segmentrevenue external2025-04-01 → 2025-09-30¥7.6bn
Medical Healthcarereportable segmentsegment profit2025-04-01 → 2025-09-30¥208m
Safetyreportable segmentrevenue2025-04-01 → 2025-09-30¥49.7bn
Safetyreportable segmentrevenue external2025-04-01 → 2025-09-30¥49.7bn
Safetyreportable segmentsegment profit2025-04-01 → 2025-09-30¥2.7bn
Smartreportable segmentrevenue2025-04-01 → 2025-09-30¥18.2bn
Smartreportable segmentrevenue external2025-04-01 → 2025-09-30¥18.2bn
Smartreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥67m
Smartreportable segmentsegment profit2025-04-01 → 2025-09-30¥404m
—segment totalrevenue2025-04-01 → 2025-09-30¥280.7bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥274.6bn
—segment totalrevenue intersegment2025-04-01 → 2025-09-30¥6.1bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥19.7bn
Total Of Reportable Segments And Otherssegment totalrevenue2025-04-01 → 2025-09-30¥290.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-04-01 → 2025-09-30¥277.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2025-04-01 → 2025-09-30¥13.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2025-04-01 → 2025-09-30¥20.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥9.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥2.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-04-01 → 2024-09-30¥7.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥344m
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥13.8bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥13.8bn
Engineering Plasticsreportable segmentrevenue2024-04-01 → 2024-09-30¥124.6bn
Engineering Plasticsreportable segmentrevenue external2024-04-01 → 2024-09-30¥124.5bn
Engineering Plasticsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥96m
Engineering Plasticsreportable segmentsegment profit2024-04-01 → 2024-09-30¥15.2bn
Materialsreportable segmentrevenue2024-04-01 → 2024-09-30¥95.1bn
Materialsreportable segmentrevenue external2024-04-01 → 2024-09-30¥88.5bn
Materialsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥6.6bn
Materialsreportable segmentsegment profit2024-04-01 → 2024-09-30¥14.3bn
Medical Healthcarereportable segmentrevenue2024-04-01 → 2024-09-30¥7.2bn
Medical Healthcarereportable segmentrevenue external2024-04-01 → 2024-09-30¥7.2bn
Medical Healthcarereportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥0
Medical Healthcarereportable segmentsegment profit2024-04-01 → 2024-09-30¥189m
Safetyreportable segmentrevenue2024-04-01 → 2024-09-30¥47.1bn
Safetyreportable segmentrevenue external2024-04-01 → 2024-09-30¥47.1bn
Safetyreportable segmentsegment profit2024-04-01 → 2024-09-30¥1.3bn
Smartreportable segmentrevenue2024-04-01 → 2024-09-30¥19.6bn
Smartreportable segmentrevenue external2024-04-01 → 2024-09-30¥19.6bn
Smartreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥51m
Smartreportable segmentsegment profit2024-04-01 → 2024-09-30¥215m
—segment totalrevenue2024-04-01 → 2024-09-30¥293.6bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥286.9bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥6.7bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥31.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥303.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥289.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥13.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥31.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 588
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)有限責任監査法人 トーマツ
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)河  津  誠  司
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)河  越  弘  昭
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1InterimDuration289688000000JPY
Net sales (5-year summary)InterimDuration277119000000JPY
Net sales (5-year summary)Prior1YearDuration586531000000JPY
Ordinary income loss (5-year summary)Prior1InterimDuration30745000000JPY
Ordinary income loss (5-year summary)InterimDuration20371000000JPY
Ordinary income loss (5-year summary)Prior1YearDuration62320000000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1InterimDuration32053000000JPY
Profit loss attributable to owners of parent (5-year summary)InterimDuration18802000000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration49480000000JPY
Comprehensive income (5-year summary)Prior1InterimDuration24081000000JPY
Comprehensive income (5-year summary)InterimDuration27898000000JPY
Comprehensive income (5-year summary)Prior1YearDuration30946000000JPY
Net assets (5-year summary)Prior1InterimInstant392310000000JPY
Net assets (5-year summary)InterimInstant394210000000JPY
Net assets (5-year summary)Prior1YearInstant375037000000JPY
Total assets (5-year summary)Prior1InterimInstant827832000000JPY
Total assets (5-year summary)InterimInstant848907000000JPY
Total assets (5-year summary)Prior1YearInstant813831000000JPY
Basic earnings loss per share (5-year summary)Prior1InterimDuration116.18
Basic earnings loss per share (5-year summary)InterimDuration70.90
Basic earnings loss per share (5-year summary)Prior1YearDuration181.44
Diluted earnings per share (5-year summary)Prior1InterimDuration-
Diluted earnings per share (5-year summary)InterimDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1InterimInstant0.455
Equity to asset ratio (5-year summary)InterimInstant0.447
Equity to asset ratio (5-year summary)Prior1YearInstant0.442
Net cash provided by used in operating activities (5-year summary)Prior1InterimDuration50745000000JPY
Net cash provided by used in operating activities (5-year summary)InterimDuration32755000000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration93406000000JPY
Net cash provided by used in investing activities (5-year summary)Prior1InterimDuration-29391000000JPY
Net cash provided by used in investing activities (5-year summary)InterimDuration-26530000000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration-47869000000JPY
Net cash provided by used in financing activities (5-year summary)Prior1InterimDuration-24043000000JPY
Net cash provided by used in financing activities (5-year summary)InterimDuration-7835000000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration-48855000000JPY
Cash and cash equivalents (5-year summary)Prior1InterimInstant64440000000JPY
Cash and cash equivalents (5-year summary)InterimInstant64419000000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant64767000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember266942682
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember266942682
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant266942682
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant266942682
Number of shares heldInterimInstant_No1MajorShareholdersMember39511000
Shareholding ratioInterimInstant_No1MajorShareholdersMember0.1488

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass